Variable evidence on metformin efficiency as weight-reducing and antiblastomogenic agent: causes and consequences
The growing interest to metformin in areas beyond the limits of diabetology serves as a stimulus for further evaluation of its effectiveness as a potential modulator of cancer morbidity and obesity epidemic. Gradually detectable differences in the intensity of these effects of the drug can be explai...
| Format: | Article |
|---|---|
| Language: | English |
| Published: |
Endocrinology Research Centre
2012-06-01
|
| Series: | Ожирение и метаболизм |
| Subjects: | |
| Online Access: | https://endojournals.ru/index.php/omet/article/view/6540 |